About
Radient Pharmaceuticals Corporation, formerly AMDL, Inc., is a vertically integrated specialty pharmaceutical company with three distinct business divisions that include In-Vitro diagnostics, China-based pharmaceutical manufacturing and distribution and cancer therapeutics. These business units focus on the development,... (more)
No analyst recommendations are available for ADL.BE.
Overall
| Beta: | -- |
| Market Cap (Mil.): | 4.19 |
| Shares Outstanding (Mil.): | 17.44 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| ADL.BE | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 4.05 | 3.76 |
| EPS (TTM): | -2,082.29 | -- | -- |
| ROI: | -32.85 | 2.37 | 2.30 |
| ROE: | -34.04 | 3.77 | 2.82 |
Competitors
| Price | Change | |
|---|---|---|
| Abbott Laboratories (ABT.N) | $53.03 | -0.32 |
| Baxter International Inc. (BAX.N) | $56.10 | -0.28 |
| Beckman Coulter, Inc. (BEC.N) | $63.36 | -0.71 |
| Siemens AG (SIEGn.DE) | €62.84 | -0.14 |
| Bio-Rad Laboratories, Inc. (BIO.N) | $90.90 | -2.68 |
| Bio-Rad Laboratories, Inc. (BIOb.N) | $92.48 | -0.02 |
| Roche Holding Ltd. (ROG.VX) | CHF174.70 | -1.40 |
| Johnson & Johnson (JNJ.N) | $62.65 | -0.11 |
Earnings vs
Estimates
No consensus analysis data available.





